
When patients come in the clinic, what red flags could general practitioners be on the look out for to indicate cancer?
Clifford received a DVM from Mississippi State University College of Veterinary Medicine and an MS in animal science/virology from the University of Delaware. After completing an internship and medical oncology residency, he became a diplomate of the American College of Veterinary Internal Medicine (Oncology). He is a medical oncologist at BluePearl Malvern and the director of BluePearl Science. He is a member of the Anivive advisory board.
When patients come in the clinic, what red flags could general practitioners be on the look out for to indicate cancer?
Craig Clifford, DVM, MS, DACVIM (Oncology), and Christine Mullin, VMD, DACVIM (Oncology), discuss the logistics and implications of immunotherapy treatments for canine oncology patients.
Craig A Clifford, DVM, MS, DACVIM (Oncology) talks about Laverdia-CA1, as well as indolent lymphoma in this interview with dvm360
Craig A Clifford, DVM, MS, DACVIM (Oncology), talks about the general practitioner’s role in the care for patients with cancer
Craig A Clifford, DVM, MS, DACVIM (Oncology), talks about mast cell tumors, sharing a bit about cytological grading, treatment options, common misconceptions, and more
Craig A Clifford, DVM, MS, DACVIM (Oncology) talks about the most common bladder tumor in dogs, misdiagnosis, and the Cadet BRAF test assay
Assessing traditional and recently approved therapies for canine lymphoma
Published: June 7th 2022 | Updated:
Published: January 6th 2025 | Updated:
Published: May 27th 2025 | Updated: